Conscientious objectives: while big pharma scrambles to meet the demands of shareholders, Warren Ross looks at how two nonprofit drug firms--PolyTherics and OneWorld Health--are attempting to upset the patent cart

'Nonprofit pharma' might seem like an oxymoron, along the lines of jumbo shrimp or anecdotal evidence. And, on first hearing, it may arouse some skepticism. Industry critics are apt to [...]